한빛사
>
한빛사논문
한빛사논문
- 조회57
Cancer Immunol. Res., Mar 11 2025, | https://doi.org/10.1158/2326-6066.CIR-24-0263
Cytotoxic chemotherapy in a 3D microfluidic device induces dendritic cell recruitment and trogocytosis of cancer cells
Dohyun Park 1+, Inae Park 2+, Bohwa Han 3+, Yujin Baek 3, Dowon Moon 2, Noo Li Jeon 1,4*, Junsang Doh 1,2,3*
1BIOMAX Institute, Seoul National University, Seoul, Republic of Korea.
2Research Institute of Advanced Materials, Seoul National University, Seoul, Korea.
3Department of Materials Science and Engineering, Institute of Engineering Research, Soft Foundry Institute, Seoul National University, Seoul, Korea.
4Department of Mechanical Engineering, Institute of Advanced Machinery and Design, Seoul National University, Seoul, Korea.
+These authors contributed equally.
*Corresponding Author: Junsang Doh, Noo Li Jeon
1BIOMAX Institute, Seoul National University, Seoul, Republic of Korea.
2Research Institute of Advanced Materials, Seoul National University, Seoul, Korea.
3Department of Materials Science and Engineering, Institute of Engineering Research, Soft Foundry Institute, Seoul National University, Seoul, Korea.
4Department of Mechanical Engineering, Institute of Advanced Machinery and Design, Seoul National University, Seoul, Korea.
+These authors contributed equally.
*Corresponding Author: Junsang Doh, Noo Li Jeon
Abstract
Cytotoxic chemotherapy that kills cancer cells can also elicit anti-tumor immune responses. Therefore, understanding the immunogenic context of cytotoxic chemotherapy can improve combination immunotherapies. In this study, we sought to improve our understanding about dendritic cell (DC) dynamics in cytotoxic chemotherapy-treated tumor tissues by developing 3D microfluidic devices that enable high-resolution visualization of cellular dynamics. Specifically, microfluidic chips mimicking 3D tumor tissues were fabricated and used. Collagen gel blocks encapsulating cancer cells in microfluidics were treated with various concentrations of oxaliplatin (OXP). Then, DCs were attached on the side of the collagen gel blocks, and migration of DCs within the 3D gels was quantitatively analyzed. Interactions between OXP-treated cancer cells and DCs were observed by high-resolution time-lapse imaging. Active infiltration of DCs was predominantly observed when OXP was administrated, indicating OXP-treated cancer cells release factors promoting DC motility. The highest frequency of DC recruitment was detected at a moderate OXP concentration, suggesting that optimizing the dosage of cytotoxic chemotherapy is crucial in order to improve immunogenic cell death (ICD). High-resolution video microscopy revealed that DCs employ trogocytosis to disassemble dying/dead cancer cells and acquire antigens, as opposed to phagocytosing the entire cancer cells. Microfluidic chip-based observations may provide new insights for the design of new therapeutic strategies to combine chemotherapy and immunotherapy.
논문정보
- Research article
- 2025년 03월 (BRIC 등록일 2025-03-13)
- 국내 연구진
- 바이오·의료융합 > 바이오센싱 및 나노바이오물질
댓글 작성 로그인
팝업 닫기관련 링크
연구자 키워드
연구자 ID
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
